{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T09:09:50Z","timestamp":1784538590606,"version":"3.55.0"},"reference-count":18,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T00:00:00Z","timestamp":1774224000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartrhythmopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart Rhythm O2"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.hroo.2026.03.026","type":"journal-article","created":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T08:36:32Z","timestamp":1774600592000},"page":"1289-1301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Indication and electrical performance of conventional, resynchronization, and conduction system pacing in transthyretin amyloid cardiomyopathy"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2220-9799","authenticated-orcid":false,"given":"Stephan","family":"Dobner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serlha","family":"Tawo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Noti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabian","family":"Wieser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Gr\u00e4ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Nitsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Reichlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lukas","family":"Hunziker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Haeberlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hroo.2026.03.026_bib1","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1016\/j.jacc.2019.04.003","article-title":"Transthyretin amyloid cardiomyopathy: JACC state-of-the-art review","volume":"73","author":"Ruberg","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib2","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacep.2020.01.004","article-title":"Management of arrhythmias in cardiac amyloidosis","volume":"6","author":"Giancaterino","year":"2020","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib3","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1111\/jce.14180","article-title":"Cardiac devices in patients with transthyretin amyloidosis: impact on functional class, left ventricular function, mitral regurgitation, and mortality","volume":"30","author":"Donnellan","year":"2019","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib4","doi-asserted-by":"crossref","first-page":"5291","DOI":"10.3390\/jcm13175291","article-title":"Effect of timely availability of TTR-stabilizing therapy on diagnosis, therapy, and clinical outcomes in ATTR-CM","volume":"13","author":"Dobner","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.hroo.2026.03.026_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022859","article-title":"Lack of association between neurohormonal blockade and survival in transthyretin cardiac amyloidosis","volume":"10","author":"Cheng","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2026.03.026_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.119.006075","article-title":"Expert consensus recommendations for the suspicion and diagnosis of transthyretin cardiac amyloidosis","volume":"12","author":"Maurer","year":"2019","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hroo.2026.03.026_bib7","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008225","article-title":"Avoiding catastrophe: understanding free light chain testing in the evaluation of ATTR amyloidosis","volume":"14","author":"Witteles","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/j.hroo.2026.03.026_bib8","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/europace\/euad043","article-title":"EHRA clinical consensus statement on conduction system pacing implantation: endorsed by the Asia Pacific Heart Rhythm Society (APHRS), Canadian Heart Rhythm Society (CHRS), and Latin American Heart Rhythm Society (LAHRS)","volume":"25","author":"Burri","year":"2023","journal-title":"Europace"},{"key":"10.1016\/j.hroo.2026.03.026_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.jacep.2024.09.041","article-title":"Predictive value of right ventricular sensing during cardiac device implantation to diagnose cardiac amyloidosis","volume":"11","author":"Hamon","year":"2025","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpcardiol.2024.102886","article-title":"Comparison of left bundle branch area pacing between patients with pacing-induced cardiomyopathy and non-ischemic dilated cardiomyopathy","volume":"50","author":"Perea-Armijo","year":"2025","journal-title":"Curr Probl Cardiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jacep.2023.08.031","article-title":"Outcomes of upgrading to LBBP in CRT nonresponders: a prospective, multicenter, nonrandomized, case-control study","volume":"10","author":"Chen","year":"2024","journal-title":"JACC Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017335","article-title":"Cardiac resynchronization therapy for transthyretin cardiac amyloidosis","volume":"9","author":"Donnellan","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2026.03.026_bib13","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.125.043049","article-title":"Cardiac resynchronization therapy, remodeling, and outcome in patients with amyloid transthyretin cardiomyopathy","volume":"14","author":"Aimo","year":"2025","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.hroo.2026.03.026_bib14","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/j.jaccas.2020.04.040","article-title":"Left bundle branch pacing in transthyretin cardiac amyloidosis and alternating bundle branch block","volume":"2","author":"Ahmed","year":"2020","journal-title":"JACC Case Rep"},{"key":"10.1016\/j.hroo.2026.03.026_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/pace.14894","article-title":"Feasibility and safety of left bundle branch area pacing in cardiac amyloidosis. A single center experience","volume":"47","author":"Pham-Trung","year":"2024","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib16","article-title":"Left bundle branch area pacing for chronic heart failure with transthyretin cardiac amyloidosis","volume":"25","author":"Sudo","year":"2024","journal-title":"Eur Heart J Cardiovasc Imaging"},{"key":"10.1016\/j.hroo.2026.03.026_bib17","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1001\/jamacardio.2022.5320","article-title":"Effect of personalized accelerated pacing on quality of life, physical activity, and atrial fibrillation in patients with preclinical and overt heart failure with preserved ejection fraction: the myPACE randomized clinical trial","volume":"8","author":"Infeld","year":"2023","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hroo.2026.03.026_bib18","article-title":"Personalized accelerated physiologic dual rate pacing for cardiac amyloidosis","volume":"29","author":"Meyer","year":"2024","journal-title":"JACC Case Rep"}],"container-title":["Heart Rhythm O2"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826001364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666501826001364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T08:58:55Z","timestamp":1784537935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666501826001364"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":18,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2666501826001364"],"URL":"https:\/\/doi.org\/10.1016\/j.hroo.2026.03.026","relation":{},"ISSN":["2666-5018"],"issn-type":[{"value":"2666-5018","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indication and electrical performance of conventional, resynchronization, and conduction system pacing in transthyretin amyloid cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Heart Rhythm O2","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hroo.2026.03.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Heart Rhythm Society. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}